Aim Immunotech INC. (AIM) SEC Filings — 2024
40 SEC filings for Aim Immunotech INC. (AIM) in 2024.
Filings
- AIM ImmunoTech Appoints New Chief Medical Officer — 8-K · Dec 23, 2024
- AIM ImmunoTech Files 8-K on Shareholder Vote Matters — 8-K · Dec 20, 2024
- AIM ImmunoTech Distributes Stockholder Correspondence — DEFA14A · Dec 17, 2024
- AIM ImmunoTech: Ownership Filing Amendment — SC 13D/A · Dec 17, 2024
- AIM ImmunoTech Files Definitive Proxy Materials — DEFA14A · Dec 16, 2024
- AIM ImmunoTech Files Definitive Proxy Materials — DEFA14A · Dec 12, 2024
- AIM ImmunoTech Files Proxy Materials — DEFA14A · Dec 10, 2024
- AIM ImmunoTech Files Proxy Materials — DEFA14A · Dec 9, 2024
- AIM ImmunoTech Files Proxy Materials — DEFA14A · Dec 6, 2024
- AIM ImmunoTech Files Proxy Materials — DEFA14A · Dec 5, 2024
- AIM ImmunoTech Files Proxy Materials — DEFA14A · Dec 4, 2024
- AIM ImmunoTech Files Proxy Materials — DEFA14A · Dec 2, 2024
- AIM ImmunoTech Files 8-K: Regulation FD, Other Events — 8-K · Nov 27, 2024
- AIM ImmunoTech Files Proxy Materials — DEFA14A · Nov 25, 2024
- AIM ImmunoTech Files Proxy Statement — DEFA14A · Nov 22, 2024
- AIM ImmunoTech Files S-1 for Public Offering — S-1 · Nov 15, 2024
- AIM ImmunoTech Files Q3 2024 10-Q — 10-Q · Nov 14, 2024
- Aim Immunotech INC. SC 13G Filing — SC 13G · Nov 14, 2024
- AIM ImmunoTech Files Definitive Proxy Materials — DEFA14A · Nov 8, 2024
- AIM ImmunoTech Files Proxy Statement — DEFA14A · Nov 4, 2024
- AIM ImmunoTech Files 8-K: Agreements, Equity Sales, and Financials — 8-K · Oct 1, 2024
- AIM ImmunoTech CFO Departs, New Director Appointed, $10M Stock Sale — 8-K · Sep 12, 2024
- Sweeney & Kellner Amend AIM ImmunoTech Filing — SC 13D/A · Sep 11, 2024
- AIM ImmunoTech: Ownership Update Filed — SC 13D/A · Sep 3, 2024
- AIM ImmunoTech Files Q2 2024 10-Q — 10-Q · Aug 14, 2024
- AIM ImmunoTech: Ownership Filing Amendment — SC 13D/A · Aug 14, 2024
- AIM ImmunoTech Files 8-K for Bylaw Amendments & Financials — 8-K · Aug 1, 2024
- AIM ImmunoTech: Ownership Filing Amendment — SC 13D/A · Jul 30, 2024
- AIM ImmunoTech Sells Ampligen Business for $10M — 8-K · Jul 15, 2024
- AIM ImmunoTech Ownership Update Filed — SC 13D/A · Jul 15, 2024
- AIM ImmunoTech Files S-1 for Public Offering — S-1 · Jul 11, 2024
- AIM ImmunoTech Raises $10M, Secures New Credit Line — 8-K · Jun 3, 2024
- AIM ImmunoTech Inc. Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 15, 2024
- AIM ImmunoTech Inc. Files S-1 Registration Statement — S-1 · Apr 19, 2024
- AIM ImmunoTech Inc. Files 2023 Annual Report on Form 10-K — 10-K · Apr 1, 2024
- AIM ImmunoTech Enters Material Agreement, Creates Financial Obligation — 8-K · Feb 20, 2024
- AIM ImmunoTech Files Routine 8-K for Reg FD & Exhibits — 8-K · Feb 9, 2024
- AIM ImmunoTech Updates Corporate Address in 8-K Filing — 8-K · Jan 25, 2024
- AIM ImmunoTech Files 8-K for Regulation FD Disclosure — 8-K · Jan 10, 2024
- Deutsch & Kellner Group Maintain Significant AIM ImmunoTech Stake — SC 13D/A · Jan 3, 2024